Skip to main content

Climb Bio, Inc.

CLYM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001768446

In the last 90 days, Climb Bio, Inc. insiders filed 0 open-market purchases and 1 sale; 108 institutions reported holding it in 13F filings for Q2 2026, worth $734.3M in total; no superinvestor holds it.

Holders of 5% or more of CLYM

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Climb Bio, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of CLYM
HolderLatest formStakeChangeFirst filedLatest filingFiling
Ra Capital Management, L.P.13D/A33.00%23.9M shares0.00 ppfrom 33.00%Aug 19, 202112 filingsNov 9, 2026SEC
FMR LLC13G/A15.00%8.62M shares+3.10 ppfrom 11.90%Jul 8, 20262 filingsNov 5, 2026SEC
Pontifax Management 4 G.P. (2015) Ltd.13G7.70%5.21M sharesNewSep 18, 20251 filingSep 18, 2025SEC
Flynn James E13G5.25%3.07M sharesNewOct 28, 20261 filingOct 28, 2026SEC
BlackRock, Inc.13G5.00%2.90M sharesNewOct 27, 20261 filingOct 27, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

38 Schedule 13D and 13G filings on Climb Bio, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on CLYM
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 9, 20265:32 PM ETRa Capital Management, L.P.and 4 others13D/A33.00%23.9M shares0.00 ppfrom 33.00%Nov 5, 2026SEC
Nov 5, 20261:14 PM ETFMR LLCand 1 other13G/A15.00%8.62M shares+3.10 ppfrom 11.90%Sep 30, 2026SEC
Oct 28, 20268:51 AM ETFlynn James Eand 3 others13G5.25%3.07M sharesNewOct 27, 2026SEC
Oct 27, 20265:25 PM ETBlackRock, Inc.13G5.00%2.90M sharesNewSep 30, 2026SEC
Aug 14, 20264:02 PM ETMPM Oncology Impact Management LP13G/A0.00%0 shares−5.60 ppfrom 5.60%Below 5%Jun 30, 2026SEC
Jul 8, 202610:11 AM ETFMR LLCand 1 other13G11.90%6.79M sharesNewJun 30, 2026SEC
Jul 7, 20264:41 PM ETRa Capital Management, L.P.and 4 others13D/A33.00%23.2M shares0.00 ppfrom 33.00%Jul 2, 2026SEC
Apr 29, 20266:44 PM ETRa Capital Management, L.P.and 5 others13D/A33.00%22.6M shares0.00 ppfrom 33.00%Apr 27, 2026SEC
Feb 17, 20264:09 PM ETMPM Oncology Impact Management LP13G5.60%2.67M sharesNewDec 31, 2025SEC
Dec 15, 20257:56 PM ETRa Capital Management, L.P.and 5 others13D/A33.00%18.0M shares–Dec 11, 2025SEC
Oct 16, 20255:48 PM ETAI Eti LLCand 3 others13D/A0.00%0 shares−5.66 ppfrom 5.66%Below 5%Oct 14, 2025SEC
Oct 7, 20254:51 PM ETAI Eti LLCand 3 others13D/A5.66%3.84M shares–Oct 3, 2025SEC
Sep 18, 20259:26 AM ETPontifax Management 4 G.P. (2015) Ltd.and 3 others13G7.70%5.21M sharesNewJun 27, 2024SEC
Feb 13, 20253:56 PM ETBML Investment Partners, L.P.and 1 other13G/A0.00%0 shares–Below 5%Dec 31, 2024SEC
Nov 14, 2024Deep Track Capital, LP13G/AOld format–––SEC
Aug 16, 2024AI Eti LLC13D/AOld format–––SEC
Aug 14, 2024Affinity Asset Advisors, LLC13G/AOld format–––SEC
Jul 2, 2024Deep Track Capital, LP13GOld format–New–SEC
Jul 1, 2024Ra Capital Management, L.P.13D/AOld format–––SEC
Jun 6, 2024Ra Capital Management, L.P.13D/AOld format–––SEC
May 17, 2024AI Eti LLC13D/AOld format–––SEC
May 17, 2024Ra Capital Management, L.P.13D/AOld format–––SEC
May 7, 2024Affinity Asset Advisors, LLC13GOld format–New–SEC
Apr 12, 2024Ra Capital Management, L.P.13D/AOld format–––SEC
Mar 18, 2024Ra Capital Management, L.P.13D/AOld format–––SEC
Feb 7, 2024BML Investment Partners, L.P.13G/AOld format–––SEC
Nov 17, 2023Ra Capital Management, L.P.13D/AOld format–––SEC
Nov 13, 2023AI Eti LLC13D/AOld format–––SEC
Apr 10, 2023Ra Capital Management, L.P.13D/AOld format–––SEC
Mar 8, 2023Intermediate Capital Group plc13G/AOld format–––SEC
Feb 14, 2023Samlyn Capital, LLC13G/AOld format–––SEC
Feb 8, 2023BML Investment Partners, L.P.13G/AOld format–––SEC
Sep 22, 2022ICG Life Sciences SCSp13GOld format–New–SEC
May 4, 2022BML Investment Partners, L.P.13GOld format–New–SEC
Apr 4, 2022Samlyn Capital, LLC13G/AOld format–––SEC
Feb 14, 2022Samlyn Capital, LLC13GOld format–New–SEC
Aug 23, 2021AI Eti LLC13DOld format–New–SEC
Aug 19, 2021Ra Capital Management, L.P.13DOld format–New–SEC

Form 144: proposed insider sales

4 notices from officers, directors and other affiliates planning to sell Climb Bio, Inc. shares, newest first.

Form 144 notices for CLYM
Filed (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
Sep 15, 20264:27 PM ETStephen ThomasDirector100.0K$1.46MSep 15, 202610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Jun 30, 20267:49 PM ETAoife BrennanOfficer · Director30.9K$407.0KJun 29, 2026E-TRADE FINANCIAL CORPORATIONSEC
Feb 25, 20264:26 PM ETStephen ThomasDirector50.0K$318.0KFeb 25, 202610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Feb 12, 20264:28 PM ETStephen ThomasDirector100.0K$556.0KFeb 12, 202610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC